Editorial
Treatment adherence as a clinical challenge in the curative treatment of breast cancer.
Laeknabladid · 02.07.2026 · 112 (0708) · 311-311
DOI: 10.17992/lbl.2026.0708.898 ↗Kurz gefasst
Editorial in der Zeitschrift Laeknabladid, online erschienen am 06.07.2026. Verfasst von Helgi Hafsteinn Helgason. Beteiligte Einrichtung: Specialist in internal medicine, medical oncology and clinical pharmacology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Specialist in internal medicine, medical oncology and clinical pharmacology.
Zitieren
APA
Helgason, H. H. (2026). Treatment adherence as a clinical challenge in the curative treatment of breast cancer. Laeknabladid, 112(0708), 311-311. https://doi.org/10.17992/lbl.2026.0708.898
Vancouver
Helgason HH. Treatment adherence as a clinical challenge in the curative treatment of breast cancer. Laeknabladid. 2026;112(0708):311-311. doi:10.17992/lbl.2026.0708.898
BibTeX
@article{Helgason2026,
author = {Helgason, Helgi Hafsteinn},
title = {Treatment adherence as a clinical challenge in the curative treatment of breast cancer},
journal = {Laeknabladid},
year = {2026},
volume = {112},
number = {0708},
pages = {311--311},
doi = {10.17992/lbl.2026.0708.898}
}
EUVIMED